New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Mark Cuban: A Master Disrupter for American Health...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
High-speed imaging tracks live brain cell activity...
World is falling behind on UN's child mortality Sustainable ...
April 16,2026
Health literacy initiative improves discharge education, rea...
April 15,2026
Constipation is common, but with simple changes, you can man...
April 14,2026
Children and teenagers more open to meat free diets—but stru...
April 13,2026
3D-printed ATLAS platform helps model cancer cell clusters b...
April 12,2026
3 million-cell map shows menopause reshapes breast tissue, p...
April 11,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Los 20 tipos de cáncer más comunes: causas, síntomas y tratamiento

Los 20 tipos de cáncer más comunes: causas, síntomas y tratamiento

Los 20 tipos de cáncer más comunes: causas, síntomas y tratamientoRepasamos cuáles son los subtipos de esta enfermedad que afectan a más gente a nivel mundial.Pol Bertran PrietoMicrobiólogo, divulgado
World medicine November 28,2023
Los 20 tipos de cáncer más comunes: causas, síntomas y tratamiento

Los 20 tipos de cáncer más comunes: causas, síntomas y tratamiento

Los 20 tipos de cáncer más comunes: causas, síntomas y tratamientoRepasamos cuáles son los subtipos de esta enfermedad que afectan a más gente a nivel mundial.Pol Bertran PrietoMicrobiólogo, divulgado
World medicine November 28,2023
Today's News
Why is Alzheimer’s disease so difficult to treat? ...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Scientists develop potential stealth cancer therapy

Scientists develop potential stealth cancer therapy

by Yale Cancer Center/Smilow Cancer HospitalCredit:ACS Central Science(2024). DOI: 10.1021/acscentsci.4c00559Sneaking by cancer's defenses, by disguising tumor-fighting antibodies insi
Oncology July 17,2024
Scientists develop potential stealth cancer therapy

Scientists develop potential stealth cancer therapy

by Yale Cancer Center/Smilow Cancer HospitalCredit:ACS Central Science(2024). DOI: 10.1021/acscentsci.4c00559Sneaking by cancer's defenses, by disguising tumor-fighting antibodies insi
Oncology July 17,2024
Study reveals dual role of protein in cancer treatment

Study reveals dual role of protein in cancer treatment

by Denise Heady,University of California, Los AngelesGraphical abstract. Credit:Cell Reports(2024). DOI: 10.1016/j.celrep.2024.114289Investigators at the UCLA Health Jonsson Comprehe
Oncology July 17,2024
Study reveals dual role of protein in cancer treatment

Study reveals dual role of protein in cancer treatment

by Denise Heady,University of California, Los AngelesGraphical abstract. Credit:Cell Reports(2024). DOI: 10.1016/j.celrep.2024.114289Investigators at the UCLA Health Jonsson Comprehe
Oncology July 17,2024
Targeted drug treatment leads tumor cells to imitate viral infection, researchers discover

Targeted drug treatment leads tumor cells to imitate viral infection, researchers discover

by Ari Navetta,Broad Institute of MIT and HarvardmIDH1 inhibition restores immune surveillance. Credit:Science(2024). DOI: 10.1126/science.adl6173A number of cancers, including certa
Oncology July 17,2024
Targeted drug treatment leads tumor cells to imitate viral infection, researchers discover

Targeted drug treatment leads tumor cells to imitate viral infection, researchers discover

by Ari Navetta,Broad Institute of MIT and HarvardmIDH1 inhibition restores immune surveillance. Credit:Science(2024). DOI: 10.1126/science.adl6173A number of cancers, including certa
Oncology July 17,2024
New tool combines evolution and AI to predict prostate cancer recurrence more than a decade ahead

New tool combines evolution and AI to predict prostate cancer recurrence more than a decade ahead

New tool combines evolution and AI to predict prostate cancer recurrence more than a decade aheadbyInstitute of Cancer ResearchStudy design. Credit:Nature Cancer(2024). DOI: 10.1038/
Nephrology & Urology July 17,2024
New tool combines evolution and AI to predict prostate cancer recurrence more than a decade ahead

New tool combines evolution and AI to predict prostate cancer recurrence more than a decade ahead

New tool combines evolution and AI to predict prostate cancer recurrence more than a decade aheadbyInstitute of Cancer ResearchStudy design. Credit:Nature Cancer(2024). DOI: 10.1038/
Nephrology & Urology July 17,2024
The origin of BPH and prostate cancer in different prostate zones and the impact on the incidence of prostate cancer

The origin of BPH and prostate cancer in different prostate zones and the impact on the incidence of prostate cancer

by Xia & He Publishing Inc.PRISMA flowchart for literature search and study selection, modified according to Page et al. Credit:Exploratory Research and Hypothesis in Medicine(2023). D
Oncology July 17,2024
The origin of BPH and prostate cancer in different prostate zones and the impact on the incidence of prostate cancer

The origin of BPH and prostate cancer in different prostate zones and the impact on the incidence of prostate cancer

by Xia & He Publishing Inc.PRISMA flowchart for literature search and study selection, modified according to Page et al. Credit:Exploratory Research and Hypothesis in Medicine(2023). D
Oncology July 17,2024
New model could reduce reliance on chemotherapy

New model could reduce reliance on chemotherapy

byAnglia Ruskin UniversityCredit: Unsplash/CC0 Public DomainA model co-designed by a professor at Anglia Ruskin University is expected to reduce the need for chemotherapy in up to 38% of breast
Oncology July 17,2024
New model could reduce reliance on chemotherapy

New model could reduce reliance on chemotherapy

byAnglia Ruskin UniversityCredit: Unsplash/CC0 Public DomainA model co-designed by a professor at Anglia Ruskin University is expected to reduce the need for chemotherapy in up to 38% of breast
Oncology July 17,2024
Personalized simulations predict patient outcomes for blood cancer treatment in breakthrough study

Personalized simulations predict patient outcomes for blood cancer treatment in breakthrough study

byUniversity of SussexComputational modeling of the cell cycle and apoptosis reveal limited impact of archetypal double hit mutations on their respective molecular networks. Credit:Blood C
Oncology July 17,2024
Personalized simulations predict patient outcomes for blood cancer treatment in breakthrough study

Personalized simulations predict patient outcomes for blood cancer treatment in breakthrough study

byUniversity of SussexComputational modeling of the cell cycle and apoptosis reveal limited impact of archetypal double hit mutations on their respective molecular networks. Credit:Blood C
Oncology July 17,2024
Have fun in the sun, but protect your skin, expert says

Have fun in the sun, but protect your skin, expert says

by Carole Tanzer MillerRoughly 20% of Americans are diagnosed with skin cancer at some point in their lives, but it's not inevitable.Skin cancer is not only the most common cancer, it's also t
Oncology July 17,2024
Have fun in the sun, but protect your skin, expert says

Have fun in the sun, but protect your skin, expert says

by Carole Tanzer MillerRoughly 20% of Americans are diagnosed with skin cancer at some point in their lives, but it's not inevitable.Skin cancer is not only the most common cancer, it's also t
Oncology July 17,2024
Ultrasonography of hepatocellular carcinoma: From diagnosis to prognosis

Ultrasonography of hepatocellular carcinoma: From diagnosis to prognosis

by Xia & He Publishing Inc.Hepatocellular carcinoma (HCC) is a prominent contributor to cancer-related mortality worldwide. Early detection and diagnosis of liver cancer can significantly improve
Oncology July 17,2024
Ultrasonography of hepatocellular carcinoma: From diagnosis to prognosis

Ultrasonography of hepatocellular carcinoma: From diagnosis to prognosis

by Xia & He Publishing Inc.Hepatocellular carcinoma (HCC) is a prominent contributor to cancer-related mortality worldwide. Early detection and diagnosis of liver cancer can significantly improve
Oncology July 17,2024
Adjuvant therapy for hepatocellular carcinoma after curative treatment: Several unanswered questions

Adjuvant therapy for hepatocellular carcinoma after curative treatment: Several unanswered questions

by Xia & He PublishingICI, immune checkpoint inhibitor. Credit: Jian-Hong Zhong, Liang Ma, Le Li, Zhen-Zhen LiHepatocellular carcinoma (HCC) is one of the most prevalent malignancies globally and
Oncology July 17,2024
Adjuvant therapy for hepatocellular carcinoma after curative treatment: Several unanswered questions

Adjuvant therapy for hepatocellular carcinoma after curative treatment: Several unanswered questions

by Xia & He PublishingICI, immune checkpoint inhibitor. Credit: Jian-Hong Zhong, Liang Ma, Le Li, Zhen-Zhen LiHepatocellular carcinoma (HCC) is one of the most prevalent malignancies globally and
Oncology July 17,2024
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu... ... Eye Infections (Updated) | Clinical Medicine ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com